For the Inventor, By the Inventor

Enter assignee name

Raritan, NJ, United States of America

Ortho Pharmaceutical Corporation

USPTO Granted Patents = 377

% Expired Patents = 0.27

CIPO Patents = 1

EPO Patents = 1

Trademarks = 4

Forward Citations = 5,709

Loading Chart...

Loading Chart...

257 inventors (with patents filed for the assignee):

Gideon Goldstein (50 out of 81 patents)

Michael P Wachter (41 out of 73 patents)

Patrick C Kung (33 out of 34 patents)

4. Jeffery B Press (30 out of 40 patents)

5. Ramesh M Kanojia (29 out of 32 patents)

6. Victor T Bandurco (19 out of 23 patents)

7. Zoltan G Hajos (19 out of 19 patents)

8. William V Murray (17 out of 49 patents)

9. Robert H Chen (17 out of 33 patents)

10. Robert Falotico (16 out of 48 patents)

11. Pauline J Sanfilippo (16 out of 21 patents)

12. Charles F Schwender (16 out of 51 patents)

13. George Heavner (15 out of 18 patents)

14. Lawrence E Lambelet, Jr (14 out of 17 patents)

15. Donald W Combs (13 out of 17 patents)

Core Competencies:

Pulmonary Surfactant

Peptide Synthesis

Drug Delivery

Anti-inflammatory Compounds

Erythropoietin

Anticonvulsant Derivatives

Oral Contraceptives

Antimicrobial Agents

Transgenic Mice

Tablet Dispenser

Therapeutic Formulations

Inhibitors

377 patents: Sort by Forward Citations

1. 8217142 - Liquid phase peptide synthesis of KL-4 pulmonary surfactant (2012-07-10),

2. 6635633 - Substituted pyrazoles (2003-10-21),

3. 6492490 - Liquid phase peptide syntheses of KL-4 pulmonary surfactant (2002-12-10),

4. 6437100 - DNA encoding a human histamine receptor of the H3 subtype (2002-08-20),

5. 6423550 - Home oral fluid sample collection device and package for mailing of such device (2002-07-23),

6. 6413743 - DNA encoding a human histamine receptor of the H3 subtype (2002-07-02),

7. 6372779 - Anti-inflammatory compounds (2002-04-16),

8. 6251956 - Combination progestin oral contraceptive regimen (2001-06-26),

9. 6235710 - Spray dried erythropoietin (2001-05-22),

10. 6221608 - Methods for identifying erythropoietin receptor binding protein (2001-04-24),

11. 6171868 - Method of sampling bodily fluids (2001-01-09),

12. 6136559 - DNA encoding as human histamine receptor of the H3 subtype (2000-10-24),

13. 6120795 - Manufacture of liposomes and lipid-protein complexes by ethanolic (2000-09-19),

14. 6071537 - Anticonvulsant derivatives useful in treating obesity (2000-06-06),

15. 6069254 - Carboxamide derivatives of piperidine for the treatment of thrombosis (2000-05-30),

Ortho Pharmaceutical Corporation, based in Raritan, NJ, specializes in the development and manufacturing of innovative pharmaceutical formulations. The company focuses on a diverse range of core technologies, including pulmonary surfactants, peptide synthesis, and advanced drug delivery systems. Their research extends to anti-inflammatory compounds, erythropoietin, anticonvulsant derivatives, oral contraceptives, and antimicrobial agents, positioning them as a key player in the pharmaceutical industry with a commitment to improving patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

377 Patents

#2 in Raritan, NJ

#64 in New Jersey

#1,220 in US

#2,443 in the World

Raritan, NJ, United States of America

Ortho Pharmaceutical Corporation

Forward Citations = 5,709

257 inventors:

Gideon Goldstein (50 out of 81 patents)

Michael P Wachter (41 out of 73 patents)

Patrick C Kung (33 out of 34 patents)

4. Jeffery B Press (30 out of 40 patents)

5. Ramesh M Kanojia (29 out of 32 patents)

Please report any incorrect information to [email protected]

Loading…